Abstract: This project presents a MATLAB-based simulation framework for antenna array design, integrating ray-tracing methods, steering vectors, and individual element patterns for real-world ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...

Japan’s IntegriCulture and Singapore’s Umami Bioworks have joined forces to leverage their cellular agriculture expertise and develop novel cosmetics from cultured fish cells. Ahead of Japan’s ...

Researchers have created the simplest artificial cell ever—just a membrane, an enzyme, and a mission. In a breakthrough that strips life down to its most basic rules, scientists at the Institute for ...

Researchers at the University of Florida (UF) and ETH Zurich have developed a device called "Marlin" to detect wireless hacking attempts on cell phones. The new device addresses vulnerabilities in ...

Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body. Led by ...

New study: two areas of the brain may work in combination to tell the brain when it’s “feeling” tired. The results may provide a way to better evaluate and treat people who experience extreme mental ...

The Earth is awash in data about itself. Every day, satellites capture around 100 terabytes of imagery. But making sense of it isn’t always easy. Seemingly simple questions can be fiendishly complex ...

HOPEWELL, N.J., June 27, 2025 /PRNewswire/ -- ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its ...

A cross-section image of cells forming a hollow sphere, called a lumenoid. The colors mark different proteins expressed by the cells inside and outside of the sphere. (Allen Institute Image) Human ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...